+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Disturbance of liver functions and dysbiosis in patients with lipid distress syndrome and its treatment with lactulose preparation "Duphalac" (lactulose)



Disturbance of liver functions and dysbiosis in patients with lipid distress syndrome and its treatment with lactulose preparation "Duphalac" (lactulose)



Rossiiskii Gastroenterologicheskii Zhurnal 2001(2): 92-102



Disturbances of liver's functions and its connection with microflora pathology of large intestine were examined in the patients with lipid dysstress-syndrome. Severe dysbiosis (reduce of light fatty acids level and increase of anaerobe index) was revealed. Efficiency of "Dufalak" (lactulose disaccharide) on liver's functions was estimated.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045814400

Download citation: RISBibTeXText

PMID: 11681193


Related references

Duphalac (lactulose) in the treatment of chronic constipation in children. Wiadomosci Lekarskie 48(1-12): 96-99, 1995

Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East Journal of Digestive Diseases 9(1): 12-19, 2017

New medicine Lactulose (Duphalac). Ugeskrift for Laeger 133(18): 889-892, 1971

Effects of purified lactulose powder (P-511), lactulose powder and lactulose syrup on the blood ammonia concentration and the pH of intestinal contents in intact rats and Eck's fistula dogs. Oyo Yakuri 54(3): 175-182, 1997

A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy. Journal of Clinical Gastroenterology 53(3): 226-230, 2019

Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. Journal of Gastroenterology and Hepatology 32(6): 1234-1239, 2017

Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy. Journal of the Association of Physicians of India 65(8): 42-46, 2017

Lactulose in the treatment of chronic portal systemic encephalopathy a prospective double blind cooperative comparison of lactulose with neomycin. Gastroenterology 67(4): 784, 1974

A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy. Journal of the Association of Physicians of India 66(1): 32-36, 2018

Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin. Journal of Laboratory and Clinical Medicine 110(3): 259-263, 1987

Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. Journal of Gastroenterology and Hepatology 27(8): 1329-1335, 2012

A comparison of lactulose breath hydrogen measurements with gut fermentation profiles in patients with fungal-type dysbiosis. Journal of Nutritional and Environmental Medicine 11(1): 33-42, 2001

A comparison of lactulose breath hydrogen measurements with gut fermentation profiles in patients with fungal-type dysbiosis. Journal of Nutritional and Environmental Medicine 14(2): 171-180, 2004

Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). Journal of Clinical Investigation 75(2): 608-613, 1985

Production of 1-lactulose and lactulose using commercial β-galactosidase from Kluyveromyces lactis in the presence of fructose. Food Chemistry 137(1-4): 1-7, 2013